Topics

Lilly's Basaglar Becomes A Blockbuster

23:30 EST 13 Feb 2020 | SCRIP

Quarterly global Basaglar sales rose above $300m for the first time in the fourth quarter of 2019, with full-year turnover...

      

Related Stories

 

Original Article: Lilly's Basaglar Becomes A Blockbuster

NEXT ARTICLE

More From BioPortfolio on "Lilly's Basaglar Becomes A Blockbuster"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...